
Chairman of the board at Lundbeck Lars Rasmussen is piling on the pressure by criticizing the company in the middle of a share price fiasco, while a growth crisis looms on the horizon.
"There is no doubt that it is disappointing that none of the treatments we had in the pipeline years ago have made it to the market. The poor internal success rate is definitely something that requires consideration," he says.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app